AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
1.05%59.521.4%$1509.69m
JNJJohnson & Johnson
0.17%139.620.7%$875.22m
PFEPfizer Inc.
-0.26%38.040.9%$788.99m
MRKMerck & Co., Inc.
-0.09%88.600.7%$686.26m
ABBVAbbVie, Inc.
-0.57%86.702.3%$666.00m
LLYEli Lilly & Co.
0.87%119.701.1%$351.70m
NVSNovartis AG
0.06%91.610.2%$147.56m
AZNAstraZeneca Plc
-1.24%47.601.2%$142.60m
RETAReata Pharmaceuticals, Inc.
-2.72%199.033.5%$135.84m
GSKGlaxoSmithKline Plc
0.18%45.150.2%$125.43m
KRTXKaruna Therapeutics, Inc.
-6.16%65.350.0%$96.71m
NVONovo Nordisk A/S
-0.53%57.070.1%$89.48m
SNYSanofi
-0.84%46.220.2%$74.33m
ALLKAllakos, Inc.
-10.88%122.740.0%$51.02m
CNSTConstellation Pharmaceuticals, Inc.
-6.94%42.810.0%$42.71m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.